Zephyrnet Logo

Tag: IPAB

Journey Through “February” on SpicyIP (2005 – Present)

<img decoding="async" width="851" height="1024" data-attachment-id="47371" data-permalink="https://spicyip.com/2024/04/journey-through-february-on-spicyip-2005-present.html/spicyip-feb" data-orig-file="https://spicyip.com/wp-content/uploads/2024/04/SpicyIP-Feb.jpeg" data-orig-size="1000,1203" data-comments-opened="1" data-image-meta="{"aperture":"0","credit":"rawpixel.com / Rijksmuseum (Source)","camera":"","caption":"Kalenderblad voor februari van de kalender 'Bloem en blad' (c. 1900 -...

Top News

Announcing the Inaugural SpicyIP Doctoral Fellow!

Our readers would have noticed that since November 2023, we have been publishing hard hitting, incisive posts by our fantastic two new SpicyIP Student...

SpicyIP Weekly Review (February 19- February 25)

Here is our recap of last week’s top IP developments. Last week we published 3 posts on the MHC’s interpretation of Section 3(d) in the...

Product-by-Process claim: DHC to the rescue

The Delhi High Court (DHC) judgement in Vifor (International) Ltd. v. MSN Laboratories Pvt. Ltd.,explaining and allowing product-by-process claims as fundamentally concerned with the product...

Legislative Oversight? Addressing the High Court Jurisdiction Vacuum Post-IPAB vis-a-vis Cancellation Petitions under the Trademark Act

Recently, the Delhi High Court referred 3 questions regarding the jurisdiction of a High Court to hear trademark rectification applications, to a larger bench....

‘Non’-Pharmaceutical Substance and Efficacy under Sec 3(d)

Can Section 3(d) be applied to a non pharmaceutical invention? The MHC in Novozymes v. Asst. Controller of Patents and Designs made some interesting...

SpicyIP Weekly Review (February 05- February 11)

After an eventful week, here is our recap of its top IP developments. Last week we published 9 posts on topics such as our...

The Ibrunitib Saga: DHC Restrains Generic Competitors, but What about Public Interest?

The Ibrutinib Patent Dispute Adding another chapter to the long-standing legal dispute concerning the Leukaemia medication Imbruvica (API Ibrutinib), the Delhi High Court on December...

2023 IPR NOTEWORTHY JUDGEMENTS AND DEVELOPMENTS- THE IP PRESS

Greetings from The IP Press! We wish you a very Happy 2024! This compilation contains the compilation of significant judgments of 2023 which are related to...

Comments on Draft IPR Division Rules of High Court at Calcutta, 2023

On December 19, 2023 the High Court at Calcutta published the draft IPR Division Rules of High Court at Calcutta, 2023 (“Calcutta Rules” or “Rules”), making...

A Look Back at India’s Top IP Developments of 2023

.  As 2023 comes to an end, in line with our annual tradition, we take stock of the top IP developments that occurred this year....

SpicyIP Weekly Review (December 18- December 24)

From an in-depth discussion on the terms of copyright and translations in India to the recent UK Supreme Court’s order regarding the patentability of...

SpicyIP Weekly Review (November 27- December 03)

Here are our summaries of the blog posts published last week along with the summaries of some interesting orders from different courts. Anything we...

Latest Intelligence

spot_img
spot_img